Biocon receives Health Canada approval for Bosaya and Vevzuo biosimilars to Prolia and Xgeva
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations
Minimally invasive laser-based procedure restores blood flow in complex arterial blockage, enables next-day discharge and improved mobility
Growth was broad-based across segments
Aims to boost speed & precision in patient care
Angelique Kruif brings over 20 years of HR leadership built across a range of international organisations
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development
The collaboration is designed to improve clinical outcomes, reduce procedural risks, and expand access to advanced image-guided treatments across a growing range of conditions
Subscribe To Our Newsletter & Stay Updated